Clinical Trials Logo

Fractional CO2 Laser clinical trials

View clinical trials related to Fractional CO2 Laser.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04577027 Not yet recruiting - Vitiligo Clinical Trials

Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of Vitiligo

Start date: January 1, 2021
Phase: Phase 4
Study type: Interventional

Vitiligo is a chronic disease with an unpredictable clinical course, characterized by the appearance of white macules and patches on the skin and mucous membranes due to the disappearance of melanocytes in the affected area. It affects approximately 0.5% - 2% of the population worldwide and may occur at any age. Vitiligo is caused by a dynamic interplay between genetic and environmental risks that initiates an autoimmune attack on melanocytes in the skin.